Table 2. The adverse events of patients with newly diagnosed GB between BV and ST groups.

Adverse Event	n (studies)	BV group		ST group		OR	P
		n(III-IV)	n(total)	n(III-IV)	n(total)
Cerebral ischemia	2	7	127	1	56	3.21 [0.39, 26.71]	0.28
Cerebral Hemorrhage	4	9	848	7	750	2.30 [0.96, 5.54]	0.06
Diarrhea	3	5	154	0	83	6.14 [0.34, 112.49]	0.22
Neutropenia	3	31	344	19	316	1.55 [0.86, 2.80]	0.15
Nausea and vomit	2	11	287	5	260	2.03 [0.70, 5.93]	0.19
Fatigue	2	48	330	21	233	1.72 [1.00, 2.96]	0.05
Hypertension	4	71	848	12	739	5.54 [2.98, 10.29]	<0.000001
Infection	3	16	154	4	83	2.29 [0.74, 7.09]	0.15
Proteinuria	2	33	431	0	560	94.24 [5.76, 1542.53]	<0.001
Thromboembolic event	4	56	805	55	766	0.97 [0.66, 1.42]	0.86
Anemia	3	9	344	7	317	1.19 [0.44, 3.23]	0.73